The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Vertex Pharmaceuticals Inc

Nasdaq: VRTX
Last

(U.S.) $107.63

Today's change-0.38 -0.35%
Updated March 30 1:45 PM EDT. Delayed by at least 15 minutes.
 

Vertex Pharmaceuticals Inc

Nasdaq: VRTX
Last

(U.S.) $107.63

Today's change-0.38 -0.35%
Updated March 30 1:45 PM EDT. Delayed by at least 15 minutes.

Reversal following new 52-week high

Vertex Pharmaceuticals Inc is lower today, dropping (U.S.)$0.38 or 0.35% to (U.S.)$107.63 after setting a new 52-week high. Over the last five days, shares have gained 20.86% and are currently 3.80% off of the 52-week high. Shares have outperformed the S&P 500 by 22.55% during the last year.

Key company metrics

  • Open(U.S.) $107.88
  • Previous close(U.S.) $108.01
  • High(U.S.) $109.73
  • Low(U.S.) $106.52
  • Bid / Ask(U.S.) $107.63 / (U.S.) $107.65
  • YTD % change+46.10%
  • Volume1,899,267
  • Average volume (10-day)2,711,666
  • Average volume (1-month)1,871,970
  • Average volume (3-month)1,846,819
  • 52-week range(U.S.) $71.46 to (U.S.) $111.88
  • Beta0.74
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward67.65×
  • Forward PEG1.01×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.46
Updated March 30 1:45 PM EDT. Delayed by at least 15 minutes.

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue459414432398
Total other revenue--------
Total revenue459414432398
Gross profit399361387348
Total cost of revenue60534450
Total operating expense419433428412
Selling / general / administrative110106112105
Research & development248272271256
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)0001
Other operating expenses, total1111
Operating income40-193-14
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax20-39-18-31
Income after tax28-40-36-36
Income tax, total-71185
Net income33-39-65-42
Total adjustments to net income--------
Net income before extra. items33-39-65-42
Minority interest51-28-6
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items33-39-65-42
Inc. avail. to common incl. extra. items33-39-65-42
Diluted net income33-39-65-42
Dilution adjustment--------
Diluted weighted average shares245245244244
Diluted EPS excluding extraordinary itemsvalue per share0.13-0.16-0.26-0.17
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.13-0.16-0.26-0.17